Form Type: 4

SEC EDGAR Link
Accession Number:0001209191-19-028497
Date:2019-05-08
Issuer: FLEXION THERAPEUTICS INC (FLXN)
Original Submission Date:

Reporting Person:

ARKOWITZ DAVID
C/O FLEXION THERAPEUTICS, INC.
10 MALL ROAD, SUITE 301 BURLINGTON, MA 01803

Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
Title of SecurityTransaction Date2a. Deemed Execution Date Transaction CodeSharesAcquired or DisposedPrice per share 5. Amount of Securities Beneficially Owned Following Reported Transaction 6. Ownership Form Direct or IndirectNature of Indirect Ownership
COMMON STOCK 2019-05-08 S 2,248 d $10.06 82,924 direct
Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, convertible securities
Title of Derivative Security Conversion or Exercise Price of Derivative Security Transaction Date Deemed Execution Date Transaction Code Number of Derivative Securities Acquired (A) or Disposed of (D) Date ExercisableExpiration Date Title and Amount of Securities Underlying Derivative Security Price of Derivative Security Number of derivative Securities Beneficially Owned Following Reported Transaction(s) Ownership Form: Direct (D) or Indirect (I) Nature of Indirect Beneficial Ownership
Footnotes
IDfootnote
f1 sale of shares of common stock pursuant to rule 10b5-1 arrangements to cover tax withholding obligations associated with the vesting of a restricted stock unit award granted to the reporting person on june 1, 2018.
WhaleWisdom Logo

Elevate your investments